SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-23-006912
Filing Date
2023-11-09
Accepted
2023-11-09 07:30:47
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cmpx20230930_10q.htm   iXBRL 10-Q 928028
2 EXHIBIT 31.1 ex_587025.htm EX-31.1 17418
3 EXHIBIT 31.2 ex_587026.htm EX-31.2 17509
4 EXHIBIT 32.1 ex_587027.htm EX-32.1 5943
5 EXHIBIT 32.2 ex_587028.htm EX-32.2 5991
  Complete submission text file 0001171843-23-006912.txt   4648503

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20230930.xsd EX-101.SCH 42600
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpx-20230930_def.xml EX-101.DEF 281068
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20230930_lab.xml EX-101.LAB 243024
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20230930_pre.xml EX-101.PRE 310493
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpx-20230930_cal.xml EX-101.CAL 34457
56 EXTRACTED XBRL INSTANCE DOCUMENT cmpx20230930_10q_htm.xml XML 758389
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 231390074
SIC: 2836 Biological Products, (No Diagnostic Substances)